- Home
- AXGN vs IMNM Comparison
AXGN vs IMNM Comparison
Compare AXGN & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXGN
- IMNM
- Stock Information
- Founded
- AXGN N/A
- IMNM 2006
- Country
- AXGN United States
- IMNM United States
- Employees
- AXGN N/A
- IMNM N/A
- Industry
- AXGN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- AXGN Health Care
- IMNM Health Care
- Exchange
- AXGN Nasdaq
- IMNM Nasdaq
- Market Cap
- AXGN 1.1B
- IMNM 1.2B
- IPO Year
- AXGN N/A
- IMNM 2020
- Fundamental
- Price
- AXGN $27.08
- IMNM $18.64
- Analyst Decision
- AXGN Strong Buy
- IMNM Strong Buy
- Analyst Count
- AXGN 7
- IMNM 8
- Target Price
- AXGN $27.71
- IMNM $25.75
- AVG Volume (30 Days)
- AXGN 921.9K
- IMNM 1.4M
- Earning Date
- AXGN 10-29-2025
- IMNM 11-06-2025
- Dividend Yield
- AXGN N/A
- IMNM N/A
- EPS Growth
- AXGN N/A
- IMNM N/A
- EPS
- AXGN N/A
- IMNM N/A
- Revenue
- AXGN $214,709,000.00
- IMNM $9,679,000.00
- Revenue This Year
- AXGN $21.57
- IMNM N/A
- Revenue Next Year
- AXGN $15.79
- IMNM $85.36
- P/E Ratio
- AXGN N/A
- IMNM N/A
- Revenue Growth
- AXGN 18.72
- IMNM N/A
- 52 Week Low
- AXGN $9.22
- IMNM $5.15
- 52 Week High
- AXGN $27.64
- IMNM $19.01
- Technical
- Relative Strength Index (RSI)
- AXGN 80.52
- IMNM 64.68
- Support Level
- AXGN $23.00
- IMNM $16.11
- Resistance Level
- AXGN $24.92
- IMNM $18.79
- Average True Range (ATR)
- AXGN 1.13
- IMNM 1.26
- MACD
- AXGN 0.12
- IMNM 0.04
- Stochastic Oscillator
- AXGN 86.79
- IMNM 91.10
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.